Speciality
Spotlight

       




 


Medicine


   

 




Kidney
Disease

  

  • Ronald 
    J  Falk,
    (University of North Carolina, Chapel Hill)

    Treatment of Lupus Nephritis – At work in
    progress


    N
    Engl J Med 2000; 343(16), 19 October 2000,
    pg.1182-83

     

    Treatment
    of lupus nephritis is unsatisfactory and the result
    with the standard immunosuppresive agent is not very
    good. Addition
    of corticosteroids to standard immunosuppressive
    drugs introduced its own adverse reaction,
    especially, since treatment has to be continued
    life-long.

     

    A
    new immunosuppressive agent, mycophenolate mofetil
    has been tried for many severe autoimmune diseases
    with good results. Treatment with mycophenolate mofetil in lupus
    nephritis improves the outcome, both with regard to
    life as well as progression of the disease.

      

 



 

           

Speciality Spotlight

       

 
Medicine
   

 

Kidney Disease
  

  • Ronald  J  Falk, (University of North Carolina, Chapel Hill)
    Treatment of Lupus Nephritis – At work in progress
    N Engl J Med 2000; 343(16), 19 October 2000, pg.1182-83
     
    Treatment of lupus nephritis is unsatisfactory and the result with the standard immunosuppresive agent is not very good. Addition of corticosteroids to standard immunosuppressive drugs introduced its own adverse reaction, especially, since treatment has to be continued life-long.
     
    A new immunosuppressive agent, mycophenolate mofetil has been tried for many severe autoimmune diseases with good results. Treatment with mycophenolate mofetil in lupus nephritis improves the outcome, both with regard to life as well as progression of the disease.
      

 

 

By |2022-07-20T16:42:03+00:00July 20, 2022|Uncategorized|Comments Off on Kidney Disease

About the Author: